Current Landscape of Immunotherapy in Breast CancerSylvia Adams, Elizabeth A. Mittendorf, Elizabeth S. Frank et al.|JAMA Oncology|2019Cited by 409
Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancerDavid B. Page, Sylvia Adams, Harry D. Bear et al.|npj Breast Cancer|2019Cited by 86
Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancerBrie Chun, David B. Page|Journal for ImmunoTherapy of Cancer|2022Cited by 18
A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancerDavid B. Page, Heather L. McArthur|npj Breast Cancer|2023Cited by 7